Cost effectiveness of treatments for relapsed/refractory multiple myeloma: response to a methodology : RE: Hornberger J, Rickert J, Dhawan R, Liwing J, Aschan J, Löthgren M. The cost effectiveness of bortezomib in relapsed/refractory multiple myeloma: Swedish perspective. European Journal of Haematology 2010; 85 (6):484–491.

✍ Scribed by Jack Ishak; Filipe Rodrigues

• Book ID: 114795347
• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 49 KB
• Volume: 87
• Category: Article
• ISSN: 0902-4441
• DOI: 10.1111/j.1600-0609.2011.01624.x